CD69 on Tumor-Infiltrating Cells Correlates With Neuroblastoma Suppression by Simultaneous PD-1 and PD-L1 Blockade
-
Published:2023-09
Issue:
Volume:289
Page:190-201
-
ISSN:0022-4804
-
Container-title:Journal of Surgical Research
-
language:en
-
Short-container-title:Journal of Surgical Research
Author:
Inoue SeiichiroORCID,
Takeuchi Yuta,
Horiuchi Yutaka,
Murakami Takashi,
Odaka Akio
Reference52 articles.
1. Tumor immunotherapy directed at PD-1;Ribas;N Engl J Med,2012
2. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial;Davis;Lancet Oncol,2020
3. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial;Geoerger;Lancet Oncol,2020
4. Nivolumab in paediatric cancer: children are not little adults;Mora;Lancet Oncol,2020
5. PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO;Siebert;OncoImmunology,2017
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献